Arrowhead Pharmaceuticals, Inc. (ARWR)
ARWR price $59.08 +0.15 +0.26%
- Ticker
- ARWR
- Price
- $59.08
- Change
- +0.15 +0.26%
- Market cap
- $8.34B
- P/E
- -26.30
- Forward P/E
- 13.41
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 60
Arrowhead Pharmaceuticals, Inc., founded in 1989 and based in Pasadena, California, is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for complex and challenging-to-treat diseases within the United States. The company's extensive therapeutic pipeline primarily leverages RNA interference (RNAi) technology. Among its advanced clinical programs are: ARO-AAT, a Phase II…